Vineet Labs Exempt from Corporate Governance Filing for Q4FY26 Due to Capital Thresholds
Vineet Laboratories Limited is exempt from filing its Q4FY26 Corporate Governance report. The company's paid-up equity capital (₹9.22 crore) and net worth (₹3.30 crore) as of March 31, 2025, are below the regulatory thresholds of ₹10 crore and ₹25 crore, respectively.
This is a standard regulatory filing related to corporate governance compliance thresholds. It does not indicate any significant change in the company's operations, financial performance, or strategic direction that would materially impact its business.
The announcement is a routine compliance filing confirming the company meets the criteria for exemption from certain corporate governance reporting requirements. It does not contain any new financial performance data or significant business developments.
Vineet Laboratories Limited has submitted a certificate to BSE Limited and National Stock Exchange of India Limited, stating the non-applicability of Corporate Governance provisions under Regulation 27(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the fourth quarter ended March 31, 2026.
This exemption is pursuant to Regulation 15(2) of the SEBI LODR Regulations, which states that listed entities with paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore, as of the last day of the previous financial year, are not required to comply with these corporate governance provisions.
As of March 31, 2025, Vineet Laboratories Limited had a paid-up equity share capital of ₹9,21,90,080 and a net worth of ₹3,29,52,887, both of which are below the specified threshold limits. Therefore, the company is exempt from filing the Quarterly Compliance Report on Corporate Governance.
The company has also undertaken to comply with the regulations within six months from the date they become applicable in the future.
What to do with a filing like this
Vineet Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under corporate governance report. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vineet Laboratories Limited. Read the original for the full detail.